Background Image
Previous Page  47 / 48 Next Page
Information
Show Menu
Previous Page 47 / 48 Next Page
Page Background

recommendations for monitoring. N Engl J

Med 2004;350:482-92.

46.

Merza Z, Blumsohn A, Mah PM, Meads

DM, McKenna SP, Wylie K, et al. Double blind

placebo controlled study of testosterone patch

therapy on bone turnover in men with

borderline hypogonadism. Int J Androl

2006;29:381-91.

47.

Amory JK, Watts NB, Easley KA, Sutton

PR, Anawalt BD, Matsumoto AM, et al.

Exogenous testosterone or testosterone with

finasteride increases bone mineral density in

older men with low serum testosterone. J Clin

Endocrinol Metab 2004; 89:503-10.

48.

Snyder PJ, Peachey H, Hannoush P, Berlin

JA, Loh L, Holmes JH, et al. Effect of

testosterone treatment on bone mineral density

in men over 65 years of age. J

ClinEndocrinolMetab 1999;84:1966-72.

49.

Marks LS, Mazer NA, Mostaghel E, Hess

DL, Dorey FJ, Epstein JI, et al. Effect of

testosterone replacement therapy on prostate

tissue in men with late onset hypogonadism: a

randomized controlled trial. JAMA 2006; 296:

2351-61.

50.

Buvat J, Maggi M, Guay A, Torres LO.

Testosterone deficiency in men: systematic

review and standard operating procedures for